Reducing direct oral anticoagulant doses without guideline indications does not lower bleeding risk but increases mortality in AF.

Faced with these conflicting results, doubts arose regarding the potential danger of the drug, and prescriptions for digoxin for hospitalized HF patients plummeted, particularly in the United States.

Low-dose digoxin did not significantly reduce the primary outcome. Over a median follow-up of 36.5 months, 238 primary-outcome events occurred in 131 of 500 patients in the digoxin group, while 291 ...

Digoxin is commonly used in patients with heart failure and atrial fibrillation and is the oldest drug in cardiovascular medicine 1. In 1997, the Digitalis Investigation Group (DIG) trial, a large ...

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

If you're the parent of a baby or a young child, you’ve probably woken up in the middle of the night to find your child crying out in pain or sweating from a fever. This situation can be scary if you ...

NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

The Food and Drug Administration approved a higher dose version of Novo Nordisk's blockbuster weight loss injection Wegovy, as the company pushes to win back market share from Eli Lilly. The high-dose ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Earlier this year, my wife and I welcomed our son ...

Tamiflu, known generically as oseltamivir, is one of the most commonly prescribed antiviral medications for influenza. It works by blocking the virus from spreading within your body, helping to reduce ...

MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...